The Synoptics Health division of the Synoptics Group focuses on imaging techniques within the clinical environment. Synoptics has been successfully developing and supplying imaging solutions to life science researchers across the globe since 1986. The new Synoptics Health division is currently utilising that expertise to provide a patented fluorescence protein detection system, which has been developed over four years in partnership with Queen Mary University of London (QMUL).